Cardarine， Also known as GW 501516, developed in the 1990s, its two most obvious advantages are increased aerobic endurance and fat breakdown ability. In athletes and bodybuilders, significant endurance enhancement can be seen, and the fat loss process can still retain muscles.
GW 501516 has been proved to reverse obesity with pre diabetes metabolic syndrome and metabolic abnormalities.
GW 50156 regulates the mechanism of burning fat and increases the ability of skeletal muscles to uptake glucose, which is beneficial for burning fat instead of carbohydrates or muscle proteins. This may effectively reduce fat in clinical applications for obese patients without muscle breakdown metabolism or hypoglycemia related effects and satiety issues.
GW 501516 also increases muscle mass, even in mice fed a very high-fat diet, it can improve glucose tolerance and reduce fat accumulation, indicating that GW 501516 may have a protective effect on obesity.